Influence of haloperidol and clozapine on some behavioral effects in rats

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 12, 2006, Pages 807-813

  Nowakowska, Elzbieta ^a   Kus, Krzysztof ^a   Krzyzanski, Wojciech ^a   Czubak, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antipsychotic drugs; CAS 52 86 8; CAS 5786 21 0; Clozapine, behavioral effects, rats; Haloperidol, behavioral effects, rats; Normothymic drug

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; MOTOR COORDINATION; NONHUMAN; RAT; SPATIAL MEMORY;

EID: 33845955942     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296791     Document Type: Article

References (48)

1. Aravagiri, M., Teper, Y., Marder, S. R., Pharmakokinetics and tissue distribution of olanzapine in rats. Biopharm. Drug Dispos. 20, 369 (1999)
2. Arnt, J., Pharmacological differences of classical and novel antipsychotics. Int. J. Clin. Psychopharmacol. 13, S7 (1998)
3. Arnt, J., Skarsfeld, T., Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18, 63 (1998)
4. Azmitia, E. C., Whitaker-Azmitia, P. M., Anatomy, cell biology, and plasticity of serotonergic system. In: Bloom, E. F., Kupfer, D. J. (eds.), Psychopharmacology: The Fourth Generation of Progress, pp. 443-449. Raven Press, New York (1995)
5. Bartus, R. T., On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163, 495 (2000)
6. Bauer, M. S., Milchner, L., What is a "mood stabilizer"? An evidence-based response. Am. J. Psychiatry 161, 3 (2004)
7. Bergman, J., Spealman, R. D., Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol. J. Pharmacol. Exp. Ther. 245, 471 (1988)
8. Boissier, J. R., Tardy, J., Diverres, J. C., Une nouvelle methode simple pour explorer l'action tranquilisante. Le test de la chiminne. Med. Exp. (Basel) 3, 81 (1960)
9. Brioni, J. D., Decker, M. W., Gamboa, L. P. et al., Muscimol injections in the medial septum impair spatial learning. Brain Res. 522, 227 (1990)
10. Buchann, R. W., Holstein, C., Breier, A., The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol. Psychiatry 36, 717 (1994)
11. Ceulemans, D. L. S., Gelders, Y. G., Hoppenbrouwers, M. L. et al., Effect of serotonin antagonists in schizophrenia: A pilot study with setoperone. Psychopharmacology 85, 329 (1985)
12. Coward, D. M., General pharmacology of clozapine. Br. J. Psychiatry 160, 5 (1992)
13. Daniel, D. G., Goldberg, T. E., Weinberger, D. R. et al., Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Am. J. Psychiatry 153, 417 (1996)
14. Dazzi, L., Seu, E., Cherchi, G., Biggio, G., Inhibition of stress-induced dopamine out in the rat prefrontal cortex by chronic treatment with olanzapine. Biol. Psychiatry 55, 477 (2004)
15. DeMontigny, C., Grunberg, E, Mayer, A. et al., Lithium induces rapid relief of depression in tricyclic antidepressant nonresponders. Br. J. Psychiatry 138, 252 (1981)
16. Gallhofer, B., Bauer, U., Gruppe, H. et al., First episode schizophrenia: the importance of compliance and preserving cognitive function. J. Pract. Psychiatry Behav. Health 2, 165 (1996A)
17. Gallhofer, B., Bauer, U., Lis, S. et al., Cognitive dysfunctions in schizophrenia comparison of treatment with atypical antipsychotic agents and conventional neuroleptics drugs. Eur. Neuropsychopharmacol. 6, 2 (1996B)
18. Goldberg, T. E., Gold, J. M., Greenberg, R. et al., Contrasts between patients with affective disorder and patients with schizophrenia on a neuropsychological test battery. Am. J. Psychiatry 150, 1355 (1993A)
19. Goldberg, T. E., Greenberg, R. D., Griffin, S. J. et al., The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. J. Psychiatry 162, 43 (1993B)
20. Grace, J., Bellus, S. B., Raulin, M. L. et al., Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning. Psychiatr. Serv. 47, 41 (1996)
21. Hagger, C., Buckley, P., Kenny, J. T. et al., Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol. Psychiatry 34, 702 (1993)
22. 2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. Eur. Neuropsychopharmacol. 5, 19 (1995)
23. Hippius, H., The history of clozapine. Psychopharmacology 99, S3 (1989)
24. Hoff, A. L., Faustman, W. O., Wienke, M. et al., The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacol. 15, 361 (1996)
25. 3 receptors in rat brain. Psychopharmacology 128, 362 (1996)
26. 3 receptor antagonist, in rats. Comparison with haloperidol and clozapine. Pharmacol. Reports 57, 161 (2005)
27. 1c receptor antagonists. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.) 245, 179 (1993)
28. Lee, M. A., Jayathilake, K., Meltzer, H. Y., A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophrenia Res. 37, 1 (1999)
29. Levin, E. D., Johansson, P. E., Cognitive effects of long-term chronic neuroleptic drug administration. Toxicologist 8, 77 (1988)
30. Lindenmayer, J. E, Iskander, A., Park, M. et al., Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenics: a prospective study. J. Clin. Psychiatry 59, 521 (1998)
31. Lourenco, G. A., Dorce, V. A., Palermo-Neto, J., Haloperidol treatments increased macrophage activity in male and female rats: influence of corticosterone and prolactin serum levels. Eur. Neuropsychopharmacol. 15, 271 (2005)
32. Meltzer, H. Y., McGurk, S. R., The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25, 233 (1999)
33. 1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol. Learn. Mem. 71, 207 (1999)
34. Moore, N. A., Tye, N. C., Axton, M. S. et al., The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J. Pharmacol. Exp. Therap. 262, 545 (1992)
35. Morris, R., Development of a water-maze procedure for studying spatial learning in a rat. J. Neurosci. Methods 11, 47 (1984)
36. 4 receptor: one decade research. Eur. J. Pharmacol. 405, 303 (2000)
37. Patel, N., Hitzemann, R., Genetics, haloperidol, and the Fos response in the basal anglia: a comparison of the C57BL/ 6J and DBA.2J inbred mouse strains. Neuropsychopharmacology 18, 480 (1998)
38. Purdon, S. E., Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr. Res. 35, 51 (1999)
39. Puzynski, S., Klosiewicz, L., Valproic acid amide in the treatment of affective and schizoaffective disorders. J. Affect. Disord. 6, 115 (1984)
40. Reynolds, G. P., receptor mechanisms in the treatment of schizophrenia. J. Psychopharmacol. 18, 340 (2004)
41. Rosengarten, H., Quartermain, D., The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats. Progr. Neuropharmacol. Biol. Psychiatry 26, 1047 (2002)
42. Rybakowski, J., Matkowski, K., Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Eur. Neuropsychopharmacol. 2, 161 (1992)
43. Skarsfeldt, T., Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology 124, 126 (1996)
44. 2 interactions in models of Parkinson's disease. Parkinsonism Relat. Disord. 10, 273 (2004)
45. Vieta, E., Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Hum. Psychopharmacol. 20, 225 (2005)
46. 2 dopamine receptors in the neuroleptic catalepsy in rats. Pol. J. Pharmacol. 47, 349 (1995)
47. Wolff, M. C., Leander, D., Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology 168, 410 (2003)
48. Zarate, C. A., Is clozapine a mood stabilizer? J. Clin. Psychiatry 56, 108 (1995)